Report Detail

Pharma & Healthcare Global Mydriatic Eyedrops Market Insights, Forecast to 2025

  • RnM2641691
  • |
  • 12 March, 2019
  • |
  • Global
  • |
  • 120 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Mydriatic Eyedrops market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Mydriatic Eyedrops market based on company, product type, end user and key regions.

This report studies the global market size of Mydriatic Eyedrops in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Mydriatic Eyedrops in these regions.
This research report categorizes the global Mydriatic Eyedrops market by top players/brands, region, type and end user. This report also studies the global Mydriatic Eyedrops market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes

Market size by Product
Atropine
Homatropine
Dolly
Others
Market size by End User
Adult
Children

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Mydriatic Eyedrops market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Mydriatic Eyedrops market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Mydriatic Eyedrops companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Mydriatic Eyedrops submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Mydriatic Eyedrops are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Mydriatic Eyedrops market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Mydriatic Eyedrops Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Mydriatic Eyedrops Market Size Growth Rate by Product
      • 1.4.2 Atropine
      • 1.4.3 Homatropine
      • 1.4.4 Dolly
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Mydriatic Eyedrops Market Size Growth Rate by End User
      • 1.5.2 Adult
      • 1.5.3 Children
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Mydriatic Eyedrops Market Size
      • 2.1.1 Global Mydriatic Eyedrops Revenue 2014-2025
      • 2.1.2 Global Mydriatic Eyedrops Sales 2014-2025
    • 2.2 Mydriatic Eyedrops Growth Rate by Regions
      • 2.2.1 Global Mydriatic Eyedrops Sales by Regions
      • 2.2.2 Global Mydriatic Eyedrops Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Mydriatic Eyedrops Sales by Manufacturers
      • 3.1.1 Mydriatic Eyedrops Sales by Manufacturers
      • 3.1.2 Mydriatic Eyedrops Sales Market Share by Manufacturers
      • 3.1.3 Global Mydriatic Eyedrops Market Concentration Ratio (CR5 and HHI)
    • 3.2 Mydriatic Eyedrops Revenue by Manufacturers
      • 3.2.1 Mydriatic Eyedrops Revenue by Manufacturers (2014-2019)
      • 3.2.2 Mydriatic Eyedrops Revenue Share by Manufacturers (2014-2019)
    • 3.3 Mydriatic Eyedrops Price by Manufacturers
    • 3.4 Mydriatic Eyedrops Manufacturing Base Distribution, Product Types
      • 3.4.1 Mydriatic Eyedrops Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Mydriatic Eyedrops Product Type
      • 3.4.3 Date of International Manufacturers Enter into Mydriatic Eyedrops Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Mydriatic Eyedrops Sales by Product
    • 4.2 Global Mydriatic Eyedrops Revenue by Product
    • 4.3 Mydriatic Eyedrops Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Mydriatic Eyedrops Breakdown Data by End User

    6 North America

    • 6.1 North America Mydriatic Eyedrops by Countries
      • 6.1.1 North America Mydriatic Eyedrops Sales by Countries
      • 6.1.2 North America Mydriatic Eyedrops Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Mydriatic Eyedrops by Product
    • 6.3 North America Mydriatic Eyedrops by End User

    7 Europe

    • 7.1 Europe Mydriatic Eyedrops by Countries
      • 7.1.1 Europe Mydriatic Eyedrops Sales by Countries
      • 7.1.2 Europe Mydriatic Eyedrops Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Mydriatic Eyedrops by Product
    • 7.3 Europe Mydriatic Eyedrops by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Mydriatic Eyedrops by Countries
      • 8.1.1 Asia Pacific Mydriatic Eyedrops Sales by Countries
      • 8.1.2 Asia Pacific Mydriatic Eyedrops Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Mydriatic Eyedrops by Product
    • 8.3 Asia Pacific Mydriatic Eyedrops by End User

    9 Central & South America

    • 9.1 Central & South America Mydriatic Eyedrops by Countries
      • 9.1.1 Central & South America Mydriatic Eyedrops Sales by Countries
      • 9.1.2 Central & South America Mydriatic Eyedrops Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Mydriatic Eyedrops by Product
    • 9.3 Central & South America Mydriatic Eyedrops by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Mydriatic Eyedrops by Countries
      • 10.1.1 Middle East and Africa Mydriatic Eyedrops Sales by Countries
      • 10.1.2 Middle East and Africa Mydriatic Eyedrops Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Mydriatic Eyedrops by Product
    • 10.3 Middle East and Africa Mydriatic Eyedrops by End User

    11 Company Profiles

    • 11.1 Novartis AG
      • 11.1.1 Novartis AG Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Novartis AG Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Novartis AG Mydriatic Eyedrops Products Offered
      • 11.1.5 Novartis AG Recent Development
    • 11.2 Allergan, Inc.
      • 11.2.1 Allergan, Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Allergan, Inc. Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Allergan, Inc. Mydriatic Eyedrops Products Offered
      • 11.2.5 Allergan, Inc. Recent Development
    • 11.3 Meda Pharmaceuticals Inc
      • 11.3.1 Meda Pharmaceuticals Inc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Meda Pharmaceuticals Inc Mydriatic Eyedrops Products Offered
      • 11.3.5 Meda Pharmaceuticals Inc Recent Development
    • 11.4 Bausch & Lomb Inc
      • 11.4.1 Bausch & Lomb Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Bausch & Lomb Inc Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Bausch & Lomb Inc Mydriatic Eyedrops Products Offered
      • 11.4.5 Bausch & Lomb Inc Recent Development
    • 11.5 Cigna
      • 11.5.1 Cigna Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Cigna Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Cigna Mydriatic Eyedrops Products Offered
      • 11.5.5 Cigna Recent Development
    • 11.6 Similasan Corporation
      • 11.6.1 Similasan Corporation Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Similasan Corporation Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Similasan Corporation Mydriatic Eyedrops Products Offered
      • 11.6.5 Similasan Corporation Recent Development
    • 11.7 Visine
      • 11.7.1 Visine Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Visine Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Visine Mydriatic Eyedrops Products Offered
      • 11.7.5 Visine Recent Development
    • 11.8 Alcon
      • 11.8.1 Alcon Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Alcon Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Alcon Mydriatic Eyedrops Products Offered
      • 11.8.5 Alcon Recent Development
    • 11.9 Viva Opti-Free
      • 11.9.1 Viva Opti-Free Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Viva Opti-Free Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Viva Opti-Free Mydriatic Eyedrops Products Offered
      • 11.9.5 Viva Opti-Free Recent Development
    • 11.10 Bausch & Lomb
      • 11.10.1 Bausch & Lomb Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Bausch & Lomb Mydriatic Eyedrops Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Bausch & Lomb Mydriatic Eyedrops Products Offered
      • 11.10.5 Bausch & Lomb Recent Development
    • 11.11 Systane
    • 11.12 Rite Aid
    • 11.13 Walgreens
    • 11.14 Staples
    • 11.15 Clear eyes

    12 Future Forecast

    • 12.1 Mydriatic Eyedrops Market Forecast by Regions
      • 12.1.1 Global Mydriatic Eyedrops Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Mydriatic Eyedrops Revenue Forecast by Regions 2019-2025
    • 12.2 Mydriatic Eyedrops Market Forecast by Product
      • 12.2.1 Global Mydriatic Eyedrops Sales Forecast by Product 2019-2025
      • 12.2.2 Global Mydriatic Eyedrops Revenue Forecast by Product 2019-2025
    • 12.3 Mydriatic Eyedrops Market Forecast by End User
    • 12.4 North America Mydriatic Eyedrops Forecast
    • 12.5 Europe Mydriatic Eyedrops Forecast
    • 12.6 Asia Pacific Mydriatic Eyedrops Forecast
    • 12.7 Central & South America Mydriatic Eyedrops Forecast
    • 12.8 Middle East and Africa Mydriatic Eyedrops Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Mydriatic Eyedrops Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Mydriatic Eyedrops. Industry analysis & Market Report on Mydriatic Eyedrops is a syndicated market report, published as Global Mydriatic Eyedrops Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Mydriatic Eyedrops market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,108.30
      4,662.45
      6,216.60
      3,627.00
      5,440.50
      7,254.00
      596,232.00
      894,348.00
      1,192,464.00
      325,377.00
      488,065.50
      650,754.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report